• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Mouse anti-Human CD14 Monoclonal antibody

The antibody against CD14 was raised in mouse using the Recombinant Human Monocyte differentiation antigen CD14 protein (20-345AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG1, purified by protein A with a purity greater than 95%. This antibody has been validated on ELISA, WB, IF, FC.

ADC-56100A

The antibody against CD14 was raised in mouse using the Recombinant Human Monocyte differentiation antigen CD14 protein (20-345AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG1, purified by protein A with a purity greater than 95%. This antibody has been validated on ELISA, WB, IF, FC.

$350.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-56100A ClonalityMonoclonal
Host SpeciesMouseTarget NameCD14
FormLiquidSpecies ReactivityHuman, Mouse, Rabbit
IsotypeIgG1Storage Buffer0.01M PBS, 0.03% Proclin 300; Constituents: 50% Glycerol, PH 7.4
Purification Method>95%, Protein A purifiedConjugateNon-conjugated
ApplicationELISA, IF, WB, FCStorageUpon receipt

Immunogen Information


Immunogen DescriptionRecombinant Human Monocyte differentiation antigen CD14 protein (20-345AA)Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDP08571
Background Information
  • Uniprot Id

    P08571

  • Target Species

    Human

  • Target Name

    CD14

  • Target Full Name

    Monocyte differentiation antigen CD14

  • Target Function

    Coreceptor for bacterial lipopolysaccharide. In concert with LBP, binds to monomeric lipopolysaccharide and delivers it to the LY96/TLR4 complex, thereby mediating the innate immune response to bacterial lipopolysaccharide (LPS). Acts via MyD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Acts as a coreceptor for TLR2:TLR6 heterodimer in response to diacylated lipopeptides and for TLR2:TLR1 heterodimer in response to triacylated lipopeptides, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Binds electronegative LDL (LDL(-)) and mediates the cytokine release induced by LDL(-).

  • Target Subcellular Location

    Cell membrane; Lipid-anchor, GPI-anchor. Secreted. Membrane raft. Golgi apparatus.

  • Target Tissue Specificity

    Detected on macrophages (at protein level). Expressed strongly on the surface of monocytes and weakly on the surface of granulocytes; also expressed by most tissue macrophages.

  • Target Research Area

    Immunology

  • Target Synonyms

    CD 14; CD_antigen=CD14; CD14; CD14 antigen; CD14 molecule; CD14_HUMAN; LPS-R; Mo2; Monocyte differentiation antigen CD14; Monocyte differentiation antigen CD14 urinary form; Monocyte differentiation antigen CD14; membrane-bound form; Myeloid cell specific leucine rich glycoprotein; Myeloid cell-specific leucine-rich glycoprotein

  • Target Background

    The protein encoded by this gene is a surface antigen that is preferentially expressed on monocytes/macrophages. It cooperates with other proteins to mediate the innate immune response to bacterial lipopolysaccharide, and to viruses. This gene has been identified as a target candidate in the treatment of SARS-CoV-2-infected patients to potentially lessen or inhibit a severe inflammatory response. Alternative splicing results in multiple transcript variants encoding the same protein.

Inquire Mouse anti-Human CD14 Monoclonal antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification